Beam Global stock jumps premarket after Q4 revenue surge; traders eye March filing (BEEM)

Beam Global stock jumps premarket after Q4 revenue surge; traders eye March filing (BEEM)

New York, Jan 14, 2026, 08:41 EST — Premarket

  • Beam Global shares rose in premarket trading after the company flagged a sharp sequential pickup in quarterly revenue.
  • Investors are looking for follow-through in audited results due by the end of March.

Beam Global shares jumped 27.7% to $2.26 in premarket trading on Wednesday after the company said preliminary fourth-quarter revenue rose more than 50% from the prior quarter. (Benzinga)

The early update matters because Beam is trying to prove it can grow outside its legacy U.S. government customer base, after a choppy year for demand and funding across parts of the EV-charging supply chain.

Investors have also been pressing smaller clean-tech vendors for cleaner revenue mix and steadier order flow. Beam’s update leans on both — more commercial customers and more business outside the United States.

Beam said the quarter was its strongest since the third quarter of 2024 and it expects to file audited financial results by March 31, 2026. CEO Desmond Wheatley said, “We grew Q4 revenues by 50% by selling new products into new markets.” (GlobeNewswire)

The company said international sales were about half of quarterly revenue, while non-government commercial revenue made up roughly 84%. Non-EV ARC products were about 70% of the quarter, it said, and EV ARC sales increased in Europe. (Stock Titan)

Beam’s products include off-grid EV charging systems and energy storage gear, a niche that can benefit from customers looking to avoid construction work and grid upgrades, but can also be lumpy quarter to quarter.

The stock last closed at $1.77 on Tuesday. (Finviz)

Even with Wednesday’s premarket jump, Beam’s shares were down about 40% over the past year, leaving it with a market value of roughly $34 million at the latest close. (MarketBeat)

One risk: the company’s figures are preliminary — early numbers that can change once auditors finish their work — and revenue strength does not automatically translate into profit or cash generation.

Traders will be watching for the March filing for details on margins, cash burn and order timing, and for any commentary on how much of the 2026 “blueprint” is already in hand as backlog rather than aspiration.

Stock Market Today

  • Novavax jumps 11.9% on Cantor Fitzgerald upgrade; eyes on 2025 sales and Matrix-M potential
    January 14, 2026, 10:14 AM EST. Novavax NVAX jumped 11.9% in the last session, closing at $8.67 on stronger-than-average volume. The move followed reports that Cantor Fitzgerald reiterated an Overweight rating with a $18 target, more than double the current price. Cantor sees 2025 sales improving as Nuvaxovid gains momentum under Sanofi's commercial leadership, and views Novavax's Matrix-M vaccine platform as a long-term asset. The stock also climbed after a four-week run of about 17.8%. Analysts expect a quarterly loss of $0.66 per share (EPS = earnings per share) and revenue of $78.41 million, down 11.2% year over year. A higher or lower revision in earnings estimates often moves prices in the near term, and Novavax currently has a Zacks Rank #3 (Hold). Ocugen, in the same space, rose 7.3%.
Wells Fargo stock slides before the bell as 2026 net interest income view disappoints
Previous Story

Wells Fargo stock slides before the bell as 2026 net interest income view disappoints

EB Games New Zealand to close all stores by Jan 31 — what happens to gift cards and preorders
Next Story

EB Games New Zealand to close all stores by Jan 31 — what happens to gift cards and preorders

Go toTop